Titan Pharmaceuticals Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | no data |
CEO ownership | n/a |
Management average tenure | no data |
Board average tenure | less than a year |
Recent management updates
Recent updates
Is Titan Pharmaceuticals (NASDAQ:TTNP) In A Good Position To Invest In Growth?
Jul 10Titan Pharma regains Nasdaq listing compliance
Dec 16Titan Pharmaceuticals announces 1-for-30 reverse stock split
Nov 30Titan Pharmaceuticals EPS misses by $0.01, beats on revenue
Nov 16Titan Pharma closes debt settlement and JT-09 acquisition
Nov 02Titan Pharma to raise $8M in stock offering
Oct 28CEO
Titan Pharmaceuticals has no CEO, or we have no data on them.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Director | less than a year | no data | no data | |
Independent Director | 2.3yrs | US$239.91k | 0.36% $ 13.3k | |
Independent Director | 1.1yrs | US$9.38k | no data | |
Director | less than a year | no data | no data |
1.0yrs
Average Tenure
51yo
Average Age
Experienced Board: TTNP's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.